Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;92(6):1440-1446.
doi: 10.1111/ans.17737. Epub 2022 Apr 25.

Male breast cancer: a Singapore perspective

Joshua S H Lim  1 , Yirong Sim  2   3   4 , Joanne Ngeow  5   6   7 , Jeanette Yuen  5 , Veronique K M Tan  2   3   4 , Benita Kiat Tee Tan  2   3   4   8 , Wei-Sean Yong  2   3   4 , Chow Yin Wong  3   4 , Sue Zann Lim  2   3   4 , Julie Liana B Hamzah  2   3   4 , Si Ying Tan  2   3   4 , Fuh Yong Wong  9 , Preetha Madhukumar  2   3   4
Affiliations

Male breast cancer: a Singapore perspective

Joshua S H Lim et al. ANZ J Surg. 2022 Jun.

Abstract

Introduction: Male breast cancer (MBC) is rare, representing <1% of all breast cancers. Treatment recommendations have been extrapolated from trial data of female breast cancer patients. This study aims to report our institutional experience of MBC across a 20 year period, analyse the survival outcome and prognosis of this group against female breast cancer patients treated at the same centre.

Methods: Clinical, histopathological, treatment and survival data of male and female breast cancer patients treated between Jan 1999 and July 2019 at Singapore General Hospital and National Cancer Centre Singapore were identified and analysed.

Results: Fifty-seven male patients were identified. The median age at diagnosis was 63 years. Majority had invasive ductal carcinoma (86%) and presented at an early disease stage: 70.2% presented as Tis/T1/T2 and 49.1% had no axillary nodal involvement. 84.2% had a simple mastectomy with either a sentinel lymph node biopsy or axillary clearance. The median follow up was 5.69 years for males and 5.83 years for females. The median survival was 11.86 years for males and 16.3 years for females. At 5 years, overall survival (OS) was 69.9% (52.3-82.1%) and disease free survival (DFS) was 62.9% (44.9-76.5%) for males compared with OS 83.8% (83.21-84.39%) and DFS 74.5% (73.91-75.09%) for females.

Conclusion: MBC remains understudied. Our institutional data indicates that good long term survival in South-East Asian patients can be achieved with treatment protocols that are similar to female breast cancer. More prospective studies are required.

Keywords: Singapore; breast cancer; male.

PubMed Disclaimer

References

    1. Korde LA, Zujewski JA, Kamin L et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J. Clin. Oncol. 2010; 28: 2114-22.
    1. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer 2004; 101: 51-7.
    1. Kwong A, Chau WW, Mang OW et al. Male breast cancer: a population-based comparison with female breast cancer in Hong Kong, southern China: 1997-2006. Ann. Surg. Oncol. 2014; 21: 1246-53.
    1. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006; 367: 595-604.
    1. Teo JY, Tan PH, Yong WS. Male breast cancer in Singapore: 15 years of experience at a single tertiary institution. Ann. Acad. Med. Singap. 2012; 41: 247-51.

LinkOut - more resources